TheAnswerPage

JANUARY 11, 2022

Well, if your answer is ‘no,’ you are definitely not alone. Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). Are you able to answer your patients’ medical marijuana questions?

Patients 98

Patients Education Marijuana Therapy 98

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Removing cannabis from the CSA, a/k/a descheduling, would not amend its legal definition in such a way that it would meet either requirement.

Business 52

Business Policy Clinical Trials Research and Development 52

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Joint Blog

JULY 25, 2020

FDA-approval on CBD Despite the rapid growth of the CBD market, there is only one FDA-approved CBD product in the United States to this day – a prescription medicine called Epidiolex that is used for treating seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in kids. In addition, 15 of the 31 products (48%) contained THC.

CBD 33

CBD Clinical Trials Safety Media 33

The Cannigma

JUNE 15, 2021

CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

Medical Cannabis Seedbank

FEBRUARY 26, 2018

states where cannabis is legalized chemo-induced nausea or vomiting is now a qualifying condition to receive THC based treatments. Unfortunately, research seems too few and far between to see significant advancements in the use of cannabis as medicine. This can become reality with continued research and funding of clinical trials.

Treatment 63

Treatment Patients Clinical Trials THC 63

CannaMD

AUGUST 8, 2020

Hemp is often used in manufacturing; whereas marijuana serves a primarily medicinal/recreational purpose. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD. One more difference? For more information, see: What Is Hemp & Why Does It Matter?

CBD 99

CBD DEA Research and Development Hemp 99

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary. One such circumstance is a clinical trial.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Veriheal

APRIL 18, 2022

F or example, the study reports a definitive correlation between accelerated aging and lifetime cannabis use. Unfortunately, research on cannabis and aging remains limited but its benefits for aging can be seen through existing research on medical conditions associated with getting older. The Final Verdict.

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98

Project CBD

MAY 3, 2023

She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. CannMed: For what conditions do you think CBG has the most promise?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Hosting clinical trials for MDMA ( MAPS Public Benefit Corporation), psilocybin (the Usona Institute), LSD (MindMed) and ketamine (the University of Utah ).

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

DECEMBER 20, 2021

Conventionally, hemp in India was used for preparing natural medicines, nutritional foods and also fibre to make textiles. Finally the definition of cannabis included ‘ flowering or fruiting tops (excluding seeds and leaves when not accompanied by tops ) from which resin is not extracted ‘ 4.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. National Library of Medicine website. Epilepsy Behav. 2022;127:108514. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

The Cannigma

APRIL 8, 2021

Listen & Subscribe: As both a regulated medicine and something people use for wellness and even recreation, the information gaps that exist for cannabis users are unprecedented. Any other medication and you’re lawfully entitled to speak to a pharmacist,” explains Dr. Codi Peterson, a clinical pharmacist and medical cannabis professional.

Medicine 112

Medicine Cannabinoids Cannabis THC 112

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Therapy 92

Therapy Legalization Chronic Pain DEA 92

Cannabis Info

OCTOBER 11, 2019

Dementia is a catch-all term for the conditions that cause declining memory and thinking skills, including Alzheimer’s, Parkinson’s and vascular dementia. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. Cannabis research in the U.S.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. Published by The Journal of Cannabis Research.

Research and Development 52

Research and Development Medicine Access Media 52

CannaMD

MARCH 8, 2020

The study touched on a number of both general and specific concerns related to marijuana’s potential role in a range of cardiovascular disorders, but ultimately offered no specific and definitive conclusions. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Legalization 53

Legalization Therapy Chronic Pain DEA 53

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. There’s a huge attempt by the industry, especially during the late 1800s, early to mid-1900s, to legitimize the practice of medicine.

Legalization 130

Legalization Patients Education Dispensary 130

The Cannigma

FEBRUARY 11, 2021

There was definitely no way of ensuring that you got the same effect from it consistently. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. Back in those days there was really no lab tested medicine at the dispensaries.

Wellness and Beauty 129

Wellness and Beauty Data Patients Medicine 129

The Cannigma

DECEMBER 22, 2021

EG: Yeah, definitely. At the moment, you said that they could potentially add more conditions. What conditions, or indications can doctors prescribe for in Israel at the moment? IR: Well, today, there is a closed list, basically, of conditions. It’s actually making decisions, what is the definition of the product?

Research and Development 83

Research and Development Oil Cannabis Clinical Trials 83

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

The Cannigma

MAY 7, 2021

This is where the crux of the issue is, if you are a patient then you have epilepsy or your child has epilepsy, you want a qualified product that you can rely on that has the same level of provision in relation to the manufacturing process as any other medicine that you would take. MSO: Let’s pivot for a minute.

Supply Chain 122

Supply Chain Patients Access Hemp 122

Weedistry

FEBRUARY 4, 2019

Critics argue that we don’t have enough evidence of weed’s effectiveness as medicine. First, plenty of pharmaceutical drugs, that we broadly accept as legitimate medicine, received approval from the U.S. For comparison, about a third of pharmaceutical medicines on the U.S. That’s simply not true.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

OCTOBER 17, 2019

Plants with a level of THC content low enough that they are considered non-intoxicating—with the specific definitions varying depending on the jurisdiction—are classified as industrial hemp. Each has different levels of a compound called tetrahydrocannibinol (THC), which is what gives marijuana users their high.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. However, the Governor is expected to veto a bill that would allow inter-island transfer of medicinal cannabis.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40